Revascularization in chronic CAD is beneficial when ischemia is proven, with the choice of surgical or interventional method depending on anatomical complexity and patient characteristics.
The primary issues must be discussed regarding the decision making of treating a patient with chronic coronary artery disease (CAD), are the appropriateness of revascularization and the method which will be applied. The criteria will be the symptoms, the evidence of ischemia and the anatomical complexity of the coronary bed. Main indications are persistence of symptoms, despite oral medical treatment and the prognosis of any intervention. The prognosis is based on left ventricular function, on the number of coronary arteries with significant stenosis and the ischemic burden. For patients with symptoms and no evidence of ischemia, there is no benefit from revascularization. If ischemia is proven, revascularization is beneficial. If revascularization is decided, the next important issue must be taken under consideration is the choice of the appropriate method to be applied, surgical or interventional approach. Current treatment options will be presented.
No takes yet. Share an insight, caveat, or question.
Prapas et al. (2014) conducted an editorial in Chronic coronary artery disease (n=1,077). Arterial Π-Circuit-Greek Pi-Circuit with OPCAB was evaluated on 30-day mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: